United States · Platforms & data · MarketBeat
NovoCure Q3 Earnings Call Highlights
NovoCure (NASDAQ:NVCR) reported third-quarter 2026 net revenue of $193 million, up 16% from a year earlier, as growth in its Optune Gio business and an expanding launch of Optune…
Read the full article on MarketBeat Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)



